YD Bio Limited Ordinary Shares
YDES · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $389 | $354 | $381 | $260 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $389 | $354 | $381 | $260 |
| Operating Income | -$389 | -$354 | -$381 | -$260 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$1,827 | -$3,012 | $799 | $2,438 |
| Pre-Tax Income | -$2,216 | -$3,366 | $418 | $2,178 |
| Tax Expense | -$2 | $2 | $0 | -$12 |
| Net Income | -$2,215 | -$3,368 | $418 | $2,190 |
| % Margin | – | – | – | – |
| EPS | -0.65 | -0.98 | 0.1 | 0.54 |
| % Growth | 33.7% | -1,080% | -81.5% | – |
| EPS Diluted | -0.65 | -0.98 | 0.1 | 0.54 |
| Weighted Avg Shares Out | 3,409 | 3,419 | 4,034 | 4,034 |
| Weighted Avg Shares Out Dil | 3,409 | 3,419 | 4,034 | 4,034 |
| Supplemental Information | – | – | – | – |
| Interest Income | $35 | $35 | $122 | $136 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2,216 | -$3,366 | $418 | $2,178 |
| % Margin | – | – | – | – |